Healthcare & Biotech

Tucson – September 13, 2026 -- Delta Development Team (DDT) has launched BloodCOMM®, a cloud-based blood management platform designed to digitize and automate blood supply chain tracking for hospitals, blood centers, EMS agencies, and air medical providers.

Platform creates digital identity for every blood unit from collection to disposition

BloodCOMM® uses barcode scanning, AI-powered label recognition, and automated event tracking to monitor blood unit location, temperature, expiration status, inspections, transfers, and excursions throughout the product lifecycle. The system builds a digital cold chain of custody record, capturing patient identifiers, product details, and deviation history as events occur rather than reconstructing them from paper logs or spreadsheets after the fact.

Jacksonville, Fla. – September 13, 2026 -- Alan Alwakeel, a recent graduate of Stanton College Preparatory School, received a $3,000 Humane Science Award from the National Anti-Vivisection Society (NAVS) for an AI-powered cancer therapy simulation platform that eliminates the need for animal testing.

Platform simulates cancer treatment efficacy without animal trials

Alwakeel's project, "The Virtual Cell 2.0: Expanding Precision and Personalized Cancer Therapy Through AI-Powered Simulation," applies computational frameworks to evaluate potential cancer treatment outcomes. The tool aims to accelerate how new therapies are developed, tested and deployed by replacing traditional animal-based testing methods with data-driven simulation.

San Francisco – September 13, 2026 -- Cionic reported that the first 60 participants in its TRANSFORM study showed an average 26% improvement in health-related quality of life after one month, using the standardized EQ-5D-5L instrument across all five measured dimensions.

Cionic launches 12-month study tracking 1,000 adults with upper motor neuron conditions

The TRANSFORM study follows 1,000 adults with multiple sclerosis, stroke, spinal cord injury, cerebral palsy, and related conditions over 12 months, collecting quality-of-life data through six surveys administered via the Cionic mobile app at onboarding and at one, three, six, nine, and 12 months. The primary endpoint, EQ-5D-5L, measures mobility, self-care, usual activities, pain, and anxiety/depression, while secondary measures track spasticity, urinary incontinence, and fatigue.

Berlin – – September 12, 2026 -- The German Medical Association (Bundesärztekammer, BÄK) has called for suicide prevention to be treated as a core duty for physicians across all medical specialties, not just psychiatry, ahead of World Suicide Prevention Day on September 10, 2026.

Brea, Calif. – September 12, 2026 -- Envista Holdings Corporation (NYSE: NVST) will participate in a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026, from 9:40 to 10:10 AM ET.

Envista confirms live webcast access for investors

A live audio webcast of the session, along with an archived replay, will be available in the Investors section of the Envista website.

Dental industry group operates more than 30 brands

Envista's portfolio includes DEXIS, Kerr, Nobel Biocare, and Ormco, spanning dental imaging, orthodontics, and implant technologies.

Warsaw, Ind. – September 12, 2026 -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) named three internal executives to newly restructured president roles effective October 1, as Group President Kevin Thornal exits the company on September 30 following a transition period.

Gary Campbell takes over commercial strategy across the Americas

Campbell, promoted to President, Americas, will oversee commercial execution in the United States, Canada and Latin America. He has served as vice president and general manager, Orthopedics – North America, since September 2024, and joined Zimmer Biomet in 2019 after prior sales and marketing roles at Enovis.

Grand Rapids, Mich. – – September 12, 2026 -- Shoulder Innovations, Inc. (NYSE: SI) has settled all outstanding patent litigation with Catalyst OrthoScience Inc., ending a legal dispute between the two shoulder-implant makers under confidential terms.

Shoulder Innovations resolves patent dispute with Catalyst OrthoScience under sealed terms

The settlement agreement closes all pending patent claims between Shoulder Innovations and Catalyst OrthoScience without disclosing financial or licensing terms.

CEO Rob Ball says the deal protects intellectual property tied to shoulder arthroplasty innovation

"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. He said protecting intellectual property remains fundamental to ensuring continued investment benefits stakeholders, including surgeons and patients.

Topeka – September 12, 2026 -- A new 60-bed Behavioral Health Unit at the Shawnee County Jail in Topeka, Kansas, opened on August 24 following a three-year, $21 million construction project, expanding specialized care for pretrial detainees with mental health and substance use needs.

VitalCore Health Strategies backs 23,279-square-foot expansion

The addition was built to serve individuals awaiting trial who require mental health treatment, substance use support, suicide prevention, competency restoration, and other specialized services. VitalCore Health Strategies provides healthcare services at the facility under a partnership with the Shawnee County Department of Corrections that began in 2024.

Linköping – – September 12, 2026 -- Shareholders of Sectra AB (STO:SECTB) approved a combined dividend of SEK 2.30 per share at the medical imaging IT and cybersecurity company's Annual General Meeting held September 8, 2026.

Sectra sets record date for SEK 2.30 combined payout

The AGM resolved to distribute an ordinary dividend of SEK 1.30 per share plus an extraordinary dividend of SEK 1.00 per share, with remaining funds carried forward. The record date is September 10, 2026, and payment through Euroclear Sweden AB is expected September 15, 2026.

Berlin – September 12, 2026 -- More than 40% of unnecessary emergency dispatches in Germany stem from patients' lack of awareness about alternative care options, according to a survey of rescue workers commissioned by the Left party's Bundestag faction, as the federal government advances a reform plan centered on stricter patient triage for the 112 emergency line.

Rescue workers rank ignorance of care alternatives as the top cause of misdirected calls

The survey found that ambulance crews and paramedics identify unfamiliarity with non-emergency care channels -- such as general practitioners or pharmacies -- as the leading driver of avoidable 112 calls, cited in over 40% of responses. Cases range from patients calling about a tick bite to those reporting leg pain that has persisted for three weeks.